Commercial Amino Acids

Report Code: BIO007F

Publish Date: Aug 2000

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Single User License: $2750

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

  • Twenty amino acids go into making up the commercial amino acid market. This group plays many roles in a variety of fields including foods, animal feeds, cosmetics, medicines, and biotechnology as well as some industrial applications. In dollar terms, the most important current uses are in the animal feed industries and human food uses.
  • The three primary categories of commercial amino acids in the U.S. represented a billion-dollar market for the first time in 1999. The U.S. amino acid market should again surpass the billion-dollar mark in 2000 as factories across the nation and around the world increase production and sales to meet a growing demand. The U.S. amino acid market will likely surpass $1.5 billion by 2005.
  • With anticipated 2000 U.S. annual sales exceeding $800 million, the animal feed supplements market represents the largest market category for amino acids. Export sales of amino acid animal feed supplements will exceed $250 million.


INTRODUCTION

STUDY GOAL AND OBJECTIVES

This technical/marketing report updates a previous BCC, Inc. study on commercial essential amino acids. Further, the study examines the current state of the commercial essential amino acid , and presents an in-depth analysis that forecasts and tracks significant changes in the marketplace and identifies those amino acids with current or potentially greater commercial significance.

REASONS FOR DOING THIS STUDY

Commercial interest in amino acids is an outgrowth of an understanding of the many functions that these life-giving substances perform in humans and animals. As understanding of the functions and properties of amino acids increases, new commercial applications enter development, while current commercial uses continue to expand their markets on a worldwide basis.

New production technology continues to make large-scale production of these products more economical. In turn, increased availability creates newer and larger markets for these vital substances.

Amino acids gained commercial significance shortly after the turn of the century with the discovery of the flavor-enhancing quality of glutamic acid and the marketing of monosodium glutamate in Japan. Increased knowledge of the role amino acids play in the value of nutritional protein led to their being used to fortify animal feeds, as food supplements for humans, and to sustain seriously ill patients who had to be fed with intravenous solutions.

SCOPE OF THIS REPORT

This technical/market reports outlines the properties of the 20 commercial essential amino acids that are delineated in the genetic code, the current and future uses, technology, and their manufacturers. This report focuses on three commercial amino acid markets: animal feed supplements, flavoring and nutritional additives for human food, and specialty uses including medical, therapeutic, research, and industrial applications.

Feed and food applications offer steady growth opportunities to their manufacturers and their use will continue to grow both as a result of population increases and an overall increase in the worldwide standard of living.

METHODOLOGY

Much of the information in this technical/marketing report has been gathered through telephone conversations with key industry figures, as well as conversations with some of the academic experts in amino acid research. The balance of the information comes from available trade, technical, and government publications as well as an on-line data search of databases that cover all existing literature, and an evaluation of patents and company/research activities including foreign work with future applicability in the U.S.

All value of shipments and value of manufacturers' sales refer to specific markets in the U.S. International perceptions are given where appropriate. Volume and value figures are expressed in millions of pounds (lb/MM) and millions of dollars ($/MM) unless otherwise indicated. To make projections for the 2001 time period, the report relies on information regarding forces affecting specific markets, expected product introductions, and anticipated pricing.

Where precise information was not forthcoming in some cases, a consensus was made using a formulation of reasonable assumptions and estimates based on historical data. Projections are for the 2000-2005 time period.

VALUE OF THIS REPORT

This comprehensive study provides facts, data, and insights to senior market and planning executives and venture capitalists. It will assist manufacturers of products in any of the applicable markets, as well as technical personnel involved in research and development of production technology for commercial amino acids.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Commercial Amino Acids174Free
Chapter- 1: INTRODUCTION3Free
Chapter- 2: SUMMARY3Free
Chapter- 3: OVERVIEW OF AMINO ACIDS15Free
Chapter- 4: STRUCTURE OF THE INDUSTRY AND ITS COMPETITIVE ASPECTS15Free
Chapter- 5: COMMERCIAL APPLICATIONS8Free
Chapter- 6: METHIONINE11Free
Chapter- 7: LYSINE10Free
Chapter- 8: THREONINE4Free
Chapter- 9: TRYPTOPHAN8Free
Chapter- 10: CONSUMPTION OF METHIONINE, LYSINE, THREONINE AND TRYPTOPHAN IN FEEDSTUFFS5Free
Chapter- 11: FOOD FLAVORING AGENTS32Free
Chapter- 12: SPECIALTY USES56Free
Chapter- 13: APPENDIX 1: ANCILLARY COMPANIES2Free
Chapter- 14: APPENDIX 2: MEXICAN AMINO ACID SUPPLIERS2Free

Related Reports

Recent Reports

Gene Synthesis: Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO251A

The global market for Gene Synthesis is estimated to increase from $2.0 billion in 2023 to reach $4.1 billion by 2028, at a compound annual growth rate (CAGR) of 15.8% from 2023 through 2028.

Flow Cytometry: Products, Technologies and Global Markets

Published - Jun 2024 | Publisher - BCC Publishing | Code - BIO085F

The global market for flow cytometry products is expected to grow from $5.2 billion in 2023 to $8.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2029.

PEGylated Proteins Market

Published - May 2024 | Publisher - BCC Publishing | Code - BIO253A

The global market for PEGylated proteins is expected to grow from $10.2 billion in 2023 and projected to reach $15.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2023 to 2028.

Companion Diagnostics: Technologies and Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO077F

The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.

Exosome Diagnostics, Therapeutics and Research Tools: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO149E

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

Top Trending Reports

Global Market for Cell and Gene Therapy

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO225B

The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028. 

Peptide Synthesis: Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - BIO252A

The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Oligonucleotides: Global Markets

Published - Apr 2024 | Publisher - BCC Publishing | Code - BIO220B

The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.

Next-generation Sequencing: Emerging Clinical Applications and Global Markets

Published - Feb 2024 | Publisher - BCC Publishing | Code - BIO126E

The global market for clinical applications of next-generation sequencing is estimated to increase from $21.9 billion in 2023 to reach $52.9 billion by 2028, at a compound annual growth rate (CAGR) of 19.3% from 2023 through 2028.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Commercial Amino Acids
Customize Report